Analysen zu Sanofi S.A.
| 20.02.25 | Sanofi Outperform | Bernstein Research | |
| 14.02.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 13.02.25 | Sanofi Buy | UBS AG | |
| 03.02.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Sanofi Kaufen | DZ BANK | |
| 31.01.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Sanofi Hold | Deutsche Bank AG | |
| 30.01.25 | Sanofi Outperform | Bernstein Research | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Sanofi Buy | UBS AG | |
| 24.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 23.01.25 | Sanofi Buy | UBS AG | |
| 16.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 07.01.25 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | Sanofi Outperform | Bernstein Research | |
| 18.12.24 | Sanofi Sell | Deutsche Bank AG | |
| 17.12.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 17.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 17.12.24 | Sanofi Sell | Deutsche Bank AG | |
| 10.12.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 06.12.24 | Sanofi Sell | Deutsche Bank AG | |
| 03.12.24 | Sanofi Sell | Deutsche Bank AG | |
| 03.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 28.10.24 | Sanofi Sell | Deutsche Bank AG | |
| 28.10.24 | Sanofi Halten | DZ BANK | |
| 28.10.24 | Sanofi Buy | UBS AG | |
| 25.10.24 | Sanofi Buy | UBS AG | |
| 25.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 25.10.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 21.10.24 | Sanofi Buy | UBS AG | |
| 21.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 21.10.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 18.10.24 | Sanofi Buy | UBS AG | |
| 18.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 18.10.24 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 17.10.24 | Sanofi Buy | UBS AG | |
| 16.10.24 | Sanofi Sell | Deutsche Bank AG | |
| 10.10.24 | Sanofi Sell | Deutsche Bank AG | |
| 03.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 23.09.24 | Sanofi Overweight | Barclays Capital | |
| 20.09.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 12.09.24 | Sanofi Sell | Deutsche Bank AG | |
| 10.09.24 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.09.24 | Sanofi Outperform | Bernstein Research | |
| 03.09.24 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.09.24 | Sanofi Sell | Deutsche Bank AG | |
| 02.09.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 02.09.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 30.07.24 | Sanofi Sell | Deutsche Bank AG |
Aktuelle Aktienanalysen
| 16.12.25 | Volvo AB Buy | UBS AG | |
| 16.12.25 | Schneider Electric Buy | UBS AG | |
| 16.12.25 | Symrise Equal Weight | Barclays Capital | |
| 16.12.25 | Ahold Delhaize Underweight | JP Morgan Chase & Co. | |
| 16.12.25 | Carl Zeiss Meditec Halten | DZ BANK | |
| 16.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | BASF Kaufen | DZ BANK | |
| 16.12.25 | Michelin Outperform | Bernstein Research | |
| 16.12.25 | Sanofi Buy | Deutsche Bank AG | |
| 16.12.25 | L'Oréal Sell | Deutsche Bank AG | |
| 16.12.25 | GSK Hold | Deutsche Bank AG | |
| 16.12.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 16.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.12.25 | Novartis Buy | Deutsche Bank AG | |
| 16.12.25 | DEUTZ Buy | Warburg Research | |
| 16.12.25 | KION GROUP Buy | UBS AG | |
| 16.12.25 | WACKER CHEMIE Sell | Deutsche Bank AG | |
| 16.12.25 | WACKER CHEMIE Buy | UBS AG | |
| 16.12.25 | K+S Sell | UBS AG | |
| 16.12.25 | Evonik Neutral | UBS AG | |
| 16.12.25 | GEA Buy | UBS AG | |
| 16.12.25 | Daimler Truck Neutral | UBS AG | |
| 16.12.25 | RWE Buy | Deutsche Bank AG | |
| 16.12.25 | LANXESS Sell | UBS AG | |
| 16.12.25 | Nike Outperform | Bernstein Research | |
| 16.12.25 | adidas Outperform | Bernstein Research | |
| 16.12.25 | Fresenius Buy | Jefferies & Company Inc. | |
| 16.12.25 | Fresenius Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | Ferrari Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.12.25 | Airbus Overweight | Barclays Capital | |
| 16.12.25 | Fresenius Overweight | Barclays Capital | |
| 16.12.25 | Ferrari Outperform | RBC Capital Markets | |
| 15.12.25 | arGEN-X Buy | Jefferies & Company Inc. | |
| 15.12.25 | OMV Underweight | Barclays Capital | |
| 15.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | arGEN-X Buy | Goldman Sachs Group Inc. | |
| 15.12.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 15.12.25 | LVMH Moet Hennessy Louis Vuitton Buy | UBS AG | |
| 15.12.25 | arGEN-X Neutral | UBS AG | |
| 15.12.25 | Nestlé Neutral | UBS AG | |
| 15.12.25 | Novo Nordisk Neutral | UBS AG | |
| 15.12.25 | Sanofi Buy | UBS AG | |
| 15.12.25 | Sanofi Overweight | Barclays Capital | |
| 15.12.25 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | UBS Buy | Deutsche Bank AG | |
| 15.12.25 | Ströer Buy | Warburg Research | |
| 15.12.25 | Roche Hold | Deutsche Bank AG | |
| 15.12.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 15.12.25 | Polytec kaufen | Warburg Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.